Mersana Therapeutics

89 people · 0 jobs
‌

Mersana is a biopharmaceutical company specializing in the discovery and development of antibody-drug conjugate (ADC) therapies to treat patients fighting cancer.

Industries

Employees

51-200

Links


Org chart

Martin Huber
President & Chief Executive Officer
Collapse
Brian C. Deschuytner
Chief Operating Officer & Chief Financial Officer
Timothy B. Lowinger
Chief Science & Technology Officer
Alejandra Carvajal
Svp, Chief Legal Officer
Mohan Bala
SVP & Chief Development Officer
Chuck Miller
Senior Vice President, Regulatory Affairs
Adi Reske
Executive Director, Scientific Communications, Medical Affairs
Bradley J. Sumrow
Executive Medical Director
Sandra F. McManus
Vice President Of Quality, Manufacturing
Tori Caldwell
Director, Talent Acquisition
Lei Zhu
Executive Director
Vaishali Dixit
Executive Director
Baher Daoud
Executive Director, Quality Control
Vandana Singhal
Associate Director Clinical Quality Asurance
Jason Fredette
Senior Vice President, IR & Corp. Comm.
Michael Kaufman
Chief Manufacturing Officer
Robert Burger
Vice President, Clinical Development
Caryn Crasnick-Maloney
Vice President, Human Resources

Board & advisors

David Mott
Chairman
Andrew Hack
Director
Christoph Lengauer
Scientific Advisor
Howard A. Skip Burris III
Scientific Advisor
Peter A. Kiener
Scientific Advisor
K. Dane Wittrup
Scientific Advisor